The American Diabetes Association Applauds Maryland for Removing Barriers to Obesity Treatment Coverage
The Maryland General Assembly passed Senate Bill 496, enabling the state’s Medicaid program to cover comprehensive obesity treatments, including FDA‑approved weight‑loss medications, for eligible low‑income residents. The American Diabetes Association (ADA) applauded the bipartisan effort and Governor Wes Moore’s support, emphasizing that obesity deserves evidence‑based care comparable to other chronic diseases. By empowering the Maryland Department of Health to notify patients and offer these therapies, the law aims to reduce obesity‑related health disparities and long‑term diabetes costs. The ADA reaffirmed its commitment to expanding affordable, dignified care for people with obesity and diabetes.
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
New phase‑3 data presented at the ADA 2026 Scientific Sessions show that the apoC‑III inhibitor olezarsen reduces triglycerides by up to 65% and cuts acute pancreatitis incidence by 81% in diabetic patients with severe hypertriglyceridemia. In a parallel analysis, the...
The American Diabetes Association Announces Winners of the Innovation Challenge
The American Diabetes Association announced the 2026 Innovation Challenge winners at its Scientific Sessions in New Orleans. Adaptyx Biosciences, Nymble Health, and Silverstream Medical were selected for technologies that could reshape diabetes care. Winners become eligible for up to $50,000...
The American Diabetes Association’s Statement on the OMB’s Financial Assistance Proposed Rule
The White House Office of Management and Budget has proposed a rewrite of the Guidance for Federal Financial Assistance, implementing many provisions from President Trump’s 2025 executive order to tighten grant oversight. The rule would reshape reporting standards, performance metrics,...
Statement From the American Diabetes Association on the CMS’s Medicaid Work Requirements Interim Final Rule
The Centers for Medicare & Medicaid Services issued an interim final rule that will require most Medicaid beneficiaries to work, volunteer, or complete job training for at least 80 hours each month starting Jan. 1, 2027. The American Diabetes Association (ADA) warns...
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring
A new randomized controlled trial (CONNECT) presented at the ADA 2026 Scientific Sessions showed that continuous glucose monitoring (CGM) significantly improves glycemic control in adults with type 2 diabetes who are not on insulin. The study enrolled 283 participants across...
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
Investigational ultra‑long‑acting GLP‑1 receptor agonist berobenatide demonstrated that a once‑monthly 4.8 mg injection produced up to 12.3% placebo‑adjusted weight loss after 28 weeks in overweight or obese adults without diabetes, with safety comparable to the GLP‑1 class. The Phase 2b VESPER‑3 trial...
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
A new electronic‑health‑record based machine‑learning model predicts a patient’s risk of developing type 2 diabetes up to ten years in advance. The retrospective study analyzed 3,365,464 adults from Kaiser Permanente Northern California, achieving an area‑under‑the‑curve of 0.886 in training and 0.883...
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
A phase‑2 trial of acmopatide (CT‑868), the first once‑daily dual GLP‑1/GIP receptor agonist created for type 1 diabetes, showed meaningful improvements in glycemic control, weight loss, and insulin requirements. In 111 overweight adults, the 4.1 mg dose cut A1C by 0.34 percentage points,...
The American Diabetes Association Honors Senator Scott Wiener with a Lifetime Achievement Award
The American Diabetes Association presented Senator Scott Wiener with its Lifetime Achievement Award, recognizing his long‑standing advocacy for people with diabetes. Wiener’s leadership helped pass California Senate Bill 40, which caps insulin cost‑sharing at $35 per month for state‑regulated health...
PID: 58741 - Pediatric Endocrinology and Diabetes Specialists Charlotte
Advocate Health has opened a dedicated Pediatric Endocrinology and Diabetes clinic in Charlotte, North Carolina. The facility, located at 4501 Cameron Valley Parkway Suite 300, provides specialized hormone and diabetes care for children, with Spanish‑language support. It operates under program ID 7387...
The American Diabetes Association Recognized for Workplace Wellness
The American Diabetes Association (ADA) has been named a Silver‑level CareFirst Healthy Business, highlighting its sustained commitment to employee wellbeing. The award recognizes the ADA’s comprehensive wellness suite, including diabetes supply coverage, continuous glucose monitors, and mental‑health resources. ADA CEO...
The American Diabetes Association Urges California Lawmakers to Restore Access to Obesity Medications and Improve Health Through Sugary Beverage Labeling
The American Diabetes Association (ADA) is urging California lawmakers to restore Medi‑Cal coverage for GLP‑1 obesity medications and to back Senate Bill 869, which would require chain restaurants to display a clear added‑sugar icon on high‑sugar beverages. California faces a...
Beyond Blood Glucose: Managing High Triglycerides and Heart Disease Risk When Living with Diabetes
The American Diabetes Association is hosting a free webinar on September 8, 2026, titled “Beyond Blood Glucose: Managing High Triglycerides and Heart Disease Risk When Living with Diabetes.” The one‑hour session, 2‑3 PM EDT, will feature expert clinicians who discuss how to lower triglycerides,...
Meet Todd: Taking Action After Son's Type 1 Diabetes Diagnosis
Todd, whose son was diagnosed with type 1 diabetes at age 8, became actively involved in the American Diabetes Association’s Tour de Cure. He served as chairperson for the Finger Lakes region rides in 2023 and 2024, using his personal story to rally...